A Stanford-led study shows AI can accurately predict which preterm infants will suffer complications based on metabolite patterns in newborn blood samples.
Key Details
- 1AI model used dried blood spot samples from 13,536 premature infants in California, born more than 10 weeks early.
- 2Validated the algorithm on 3,299 preterm infants from Ontario, Canada.
- 3AI identified six key blood measurements, forming a metabolic health index.
- 4Combined with clinical data (gestational age, birth weight, sex, Apgar scores), the index predicted four major complications (intestinal, eye, lung, brain) with over 85% accuracy.
- 5Research published in Science Translational Medicine (DOI: 10.1126/scitranslmed.adv4942).
Why It Matters
This approach enables much more precise risk stratification for preemies, paving the way for personalized neonatal care, early intervention, and potentially reduced morbidity through targeted resource use. It represents a significant advance in applying AI to high-impact clinical prediction using routine biomedical data.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.